Encompass Health (EHC) Earnings Analysis

Encompass Health (EHC) has no confirmed upcoming earnings date. Last quarter (2026-04-30) it beat with EPS 1.6 USD vs 1.51 USD est (+6%). It has beaten estimates in 6/6 recent quarters (100%). Trailing P/E 18.26.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does EHC next report earnings?

No confirmed upcoming earnings date is currently scheduled for EHC. This page updates as the calendar is published.

EHC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-04-301.6 USD1.51 USD+6%Beat
2026-02-051.46 USD1.29 USD+13.2%Beat
2025-04-241.37 USD1.19 USD+15.1%Beat
2025-02-061.17 USD1.05 USD+11.4%Beat
2024-10-281.03 USD0.94 USD+9.6%Beat
2024-08-051.11 USD1.01 USD+9.9%Beat

Beat rate: 6/6 (100%) over reported quarters with consensus data.

EHC valuation and analyst view

Trailing P/E18.26
Trailing EPS6.141 USD
Price / book4.37
Dividend yield0.68%
Market cap10.99B
Analyst consensusBuy (21 buy / 4 hold / 1 sell)
Avg price target146 USD

Related research pages

Frequently asked questions

When is Encompass Health (EHC)'s next earnings date?

No confirmed upcoming earnings date is currently scheduled for EHC. This page updates as the calendar is published.

Did EHC beat earnings last quarter?

In its 2026-04-30 report, EHC posted EPS of 1.6 USD versus a 1.51 USD estimate — a beat of 6%.

What is EHC's earnings track record?

Over the last 6 reported quarters with consensus data, EHC beat estimates 6 times (100%).

What is EHC's current P/E ratio and EPS?

EHC trades at a trailing P/E of 18.26 on trailing EPS of 6.141129032258065 USD.

What do analysts rate EHC?

Analyst consensus is "Buy" across 26 ratings (1 strong buy, 20 buy, 4 hold, 1 sell, 0 strong sell). Average 12-month price target: 146 USD.